Latest Breaking News On - Senti bio - Page 1 : vimarsana.com

Kronos Bio Appoints Deborah Knobelman, Ph D as Chief Operating Officer and Chief Financial Officer

SAN MATEO, Calif. and CAMBRIDGE, Mass., May 21, 2024 Kronos Bio, Inc. , a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by.

United kingdomKronos bioPiper sandler cosDeborah knobelmanNorbert bischofbergerUniversity of pennsylvania school medicineAktiv pharma groupPiper jaffrayDuke universityKronos bio incAmpio pharmaceuticals incJp morgan co incCompany contactPfizer incJogo healthCorporate development

Kronos Bio Appoints Deborah Knobelman, Ph D as Chief

SAN MATEO, Calif. and CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small.

United kingdomPiper sandler cosDeborah knobelmanNorbert bischofbergerKronos bioJp morgan co incCorporate developmentKronos bio incJogo healthDuke universityAktiv pharma groupCompany contactAmpio pharmaceuticals incUniversity of pennsylvania school medicinePfizer incPiper jaffray

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesKanya rajangamSecurities exchangeSenti biosciences incHead of research developmentExchange commissionLogic gatedGene circuitChief medical officerSenti bioGene circuitsSpark therapeuticsSecurities actSecurities exchange actQuarterly reportSenti biosciences

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesKanya rajangamHead of research developmentExchange commissionSenti biosciences incSecurities exchangeLogic gatedGene circuitChief medical officerSenti bioGene circuitsSpark therapeuticsSecurities actSecurities exchange actQuarterly reportSenti biosciences

Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights

Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoTimothy luCelest therapeutics shanghai coTechnology platform comprising pooled screeningLtd celestSecurities exchangeAmerican society of geneExchange commissionLab automationSenti biosciences incInternational conventionBio announces first quarterReviews recent corporateGene circuitChief executive officer